Related Experiment Video
Updated: Apr 21, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Successful Treatment of Severe Right-Sided Heart Failure Due to Postoperative Constrictive Pericarditis With
Mitsuhiro Kanaya1, Kenichi Matsushita, Takumi Inami
1Division of Cardiology, Second Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.
Abstract:
The prognosis of inoperative constrictive pericarditis is poor due to subsequent severe right-sided heart failure that is refractory to conventional medical treatment. This case report describes the long-term treatment with tolvaptan, a new selective vasopression V2-receptor antagonist, was remarkably effective for inoperative constrictive pericarditis. Despite that tolvaptan was approved for the treatment of hyponatremia in Europe and the United States, the indications and treatment duration of it are not yet well established clinically. We propose that tolvaptan could offer an alternative option for the treatment of medically refractory severe right-sided heart failure such as constrictive pericarditis.
Related Concept Videos
Pericarditis III: Medical Management
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Heart Failure VI: Adjunct Therapies
Pericarditis IV: Nursing Management
Cardiomyopathy II: Dilated Cardiomyopathy

